Fluoroquinolone-resistant typhoid, South Africa.
Keddy
Karen H
KH
Smith
Anthony M
AM
Sooka
Arvinda
A
Ismail
Husna
H
Oliver
Stephen
S
D000368:Aged; D000890:Anti-Infective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002939:Ciprofloxacin / Q000627:therapeutic use*; D004269:DNA, Bacterial / Q000032:analysis / Q000235:genetics; D024881:Drug Resistance, Bacterial; D005260:Female; D005798:Genes, Bacterial; D006801:Humans; D008826:Microbial Sensitivity Tests; D020125:Mutation, Missense; D010802:Phylogeny; D012485:Salmonella typhi / Q000187:drug effects* / Q000302:isolation & purification; D013019:South Africa / Q000453:epidemiology; D014435:Typhoid Fever / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*
D000890:Anti-Infective Agents; D004269:DNA, Bacterial; D002939:Ciprofloxacin
J Clin Microbiol. 2005 Mar;43(3):1205-9
15750084
JAMA. 2000 May 24-31;283(20):2668-73
10819949
Bull World Health Organ. 2004 May;82(5):346-53
15298225
Epidemiol Infect. 2010 Jan;138(1):86-90
19563699
Foodborne Pathog Dis. 2006 Spring;3(1):59-67
16602980
Antimicrob Agents Chemother. 2002 Oct;46(10):3249-52
12234852
Emerg Infect Dis. 2009 Sep;15(9):1533-5
19788837
Antimicrob Agents Chemother. 2009 Sep;53(9):3832-6
19596880